Multiparametric Magnetic Resonance Imaging (MpMRI) and MRI-guided biopsy (MRGB) are the diagnostic gold standard in the management of men with suspicious prostate cancer (PCa). There are not enough studies, yet, that compare TRUS-MRGB, COG-TB and IB-MRGB. Despite IB-MRGB could be more accurate in detecting PCa in smaller lesions and a less operator dependent technique, there are still some concerns regarding high resource costs and the chance of missing lesions not visible at MRI or detected by systematic biopsy.
GetanehAMHeijnsdijkEAMde KoningHJ. The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study. Sci Rep2021; 11: 1801.
2.
SuganoDKanekoMYipW, et al. Comparative effectiveness of techniques in targeted prostate biopsy. Cancers2021; 13: 1449.
3.
OverduinCGFüttererJJBarentszJO. MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results. Curr Urol Rep2013; 14(3): 209–213.
4.
RosarioDJWaltonTJKennishSJ. In-bore multiparametric magnetic resonance imaging targeted biopsy: as good as it gets?Eur Urol2019; 75(4): 579–581.
5.
StabileADell’OglioPGandagliaG, et al. Not all multiparametric magnetic resonance imaging-targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer. Eur Urol Oncol2018; 1(2): 120–128.
6.
OssesDFvan AstenJJTijstermanJD. Cognitive-targeted versus magnetic resonance imaging-guided prostate biopsy in prostate cancer detection. Curr Urol2018; 11: 182–188.
7.
PokornyMKuaBEslerR, et al. MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature. World J Urol2019; 37(7): 1263–1279.
8.
WegelinOExterkateLvan der LeestM, et al. The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol2019; 75(4): 582–590.
9.
CostaDNGoldbergKLeonAD, et al. Magnetic resonance imaging-guided in-bore and magnetic resonance imaging-transrectal ultrasound fusion targeted prostate biopsies: an adjusted comparison of clinically significant prostate cancer detection rate. Eur Urol Oncol2019; 2(4): 397–404.
10.
BassEJPantovicAConnorMJ, et al. Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis2022; 25: 174–179.
11.
WattsKLFrechetteLMullerB, et al. Systematic review and meta-analysis comparing cognitive vs. Image-guided fusion prostate biopsy for the detection of prostate cancer. Urol Oncol2020; 38(9): 734.e19–734.e25.
12.
QueirozMRGFalsarellaPMMariottiGC, et al. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies. Abdom Radiol2019; 44(2): 732–738.
13.
AltokMKimBPatelBB, et al. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis2018; 21(4): 524–532.
14.
MerrickGSGutmanSAndreiniH, et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol2007; 52: 715–723.
